This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Innovations by Sanjay Motwani
Introduction
Sanjay Motwani is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing stable compositions for compounds that are susceptible to hydrolysis. His work has led to the filing of two patents, showcasing his innovative approach to pharmaceutical formulations.
Latest Patents
Sanjay Motwani's latest patents include a process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis. This invention involves several steps, including the addition of pharmaceutically acceptable lyophilization excipients, the use of organic solvents, and maintaining specific temperature ranges during formulation. Another significant patent is for a stable pharmaceutical composition of 5-aza-2'-deoxycitidine, which comprises non-aqueous pharmaceutical compositions and processes for their preparation. These compositions are particularly useful for treating patients suffering from myelodysplastic syndromes.
Career Highlights
Sanjay Motwani is currently associated with Fresenius Kabi Oncology Limited, where he applies his expertise in pharmaceutical innovation. His work focuses on enhancing the stability and efficacy of pharmaceutical products, contributing to advancements in cancer treatment.
Collaborations
Sanjay has collaborated with notable colleagues such as Dhiraj Khattar and Rajesh Khanna. Their combined efforts in research and development have furthered the progress of innovative pharmaceutical solutions.
Conclusion
Sanjay Motwani's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to impact the field positively, paving the way for advancements in patient care.